OTC · KDEVF
Karolinska Development AB (publ)
$0.26$0.00 (0.0%)
Karolinska Development AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 58.0% below the high.
Loading market information…
OTC · MSSTF · USD
Stock price, earnings
Quote as of Oct 24, 2023, 07:55 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Mindset Pharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.74% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mindset Pharma Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mindset Pharma Inc., headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada. A primary focus for the company is the ongoing development of MSP-1014, an investigational psychedelic compound.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:00 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.26$0.00 (0.0%)
Karolinska Development AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 58.0% below the high.
SEK 1.67-SEK 0.04 (-2.22%)
Oncopeptides AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 72.75% below the high.
$4.03+$0.03 (+0.75%)
Biostage, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.22% below the high.
$0.55-$0.01 (-1.1%)
MCI Onehealth Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.47% below the high.
$0.30$0.00 (0.0%)
Healthcare Integrated Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 38.28% below the high.
$0.82$0.00 (0.0%)
Medivir AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 8.89% below the high.
$0.03$0.00 (0.0%)
Abliva AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 25.13% below the high.
$4.08$0.00 (0.0%)
Relief Therapeutics Holding AG’s quoted price sits in the lower half of its reported 52-week range, 73.06% below the high.
